[HTML][HTML] Future perspectives on engineered T cells for cancer
Chimeric antigen receptor (CAR) T cell therapy has emerged as a revolutionary treatment for
hematological malignancies, but its adaptation to solid tumors is impeded by multiple …
hematological malignancies, but its adaptation to solid tumors is impeded by multiple …
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
G Jin, Y Liu, L Wang, Z He, X Zhao, Y Ma, Y Jia… - Nature …, 2024 - nature.com
Asthma, the most prevalent respiratory disease, affects more than 300 million people and
causes more than 250,000 deaths annually. Type 2-high asthma is characterized by …
causes more than 250,000 deaths annually. Type 2-high asthma is characterized by …
CAR T cells put the brakes on asthma
BN Lambrecht, H Hammad - Nature Immunology, 2024 - nature.com
CAR T cells put the brakes on asthma | Nature Immunology Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To …
for visiting nature.com. You are using a browser version with limited support for CSS. To …